Assembly Biosciences Stock Statistic Functions Pearson Correlation Coefficient
| ASMB Stock | USD 28.12 -0.18 -0.64% |
| Symbol |
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Pearsons Correlation Coefficient is one of the most common measures of correlation in financial statistics. It shows the linear relationship between price series of Assembly Biosciences and its benchmark or peer.
Assembly Biosciences Technical Analysis Modules
Most technical analysis of Assembly Biosciences help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Assembly from various momentum indicators to cycle indicators. When you analyze Assembly charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus infection in the United States. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California. Assembly Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 70 people. Market structure and macro sensitivity help explain how Assembly Biosciences behaves across regimes. Market sensitivity remains generally comparable to wider market conditions. Assembly Biosciences has a market cap of 444.7 M, ROE of -36.94%.
Methodology
Unless otherwise specified, financial data for Assembly Biosciences is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Assembly (USA Stocks:ASMB) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs are aggregated from public filings and market reference sources and public institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Certain values may not reflect real-time changes. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Assembly Biosciences is covered by 4 analysts. 2 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Morgan Stanley, RBC Capital Markets, Wells Fargo Securities, BMO Capital Markets, Stifel, among others. Updates may occur throughout the day.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial BoardBecome your own money manager
Tracking Assembly Biosciences inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested few shares | |
 | Hedge Favorites Invested over 20 shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Driverless Cars Invested few shares | |
 | Cash Cows Invested few shares | |
 | ESG Investing Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Disruptive Technologies Invested few shares | |
 | Impulse Invested over 200 shares | |
 | Social Domain Invested few shares | |
 | Video Games Invested few shares |
More Resources for Assembly Stock Analysis
A comprehensive view of Assembly Biosciences starts with financial statements and ratio context. Ratio context helps frame profitability, efficiency, and growth trends for Assembly Biosciences Stock. Selected reports below provide context for Assembly Stock:Assembly Biosciences has a market cap of 444.7 M, operating margin of -100.87%, ROE of -36.94%. Review Trending Equities for broader portfolio context. This reflects a position in Assembly Biosciences within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. Before investing in Assembly Stock, review our How to Buy Assembly Biosciences guide for key considerations.Analysis related to Assembly Biosciences should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Earnings Share -4.60 | Revenue Per Share | Quarterly Revenue Growth 0.576 | Return On Assets | Return On Equity |
Understanding Assembly Biosciences includes distinguishing between market value and book value, where book value reflects Assembly's accounting equity. Assembly Biosciences' market capitalization is 444.7 M. A P/B ratio of 2.44 indicates the market values Assembly Biosciences above its accounting book value. Enterprise value stands at 216.72 M. Intrinsic value reflects what Assembly Biosciences' fundamentals imply about worth, which may differ from both the trading price and the book figure. Analytical frameworks help reconcile those views.
It is useful to distinguish Assembly Biosciences' value from its trading price, which are computed with different methods. For Assembly Biosciences, key inputs include a P/B ratio of 2.44, a profit margin of -103.65%, ROE of -36.94%, and revenue of 28.52 M. The quoted price is simply the exchange level where supply meets demand.